Trial Profile
A prospective cohort study of Viread in chronic Hepatitis B patients.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Feb 2016
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- Acronyms VIREAL
- 28 Jan 2016 Results published in the Digestive Diseases and Sciences
- 24 Apr 2012 New trial record